Kairos Ventures
- Company typePrivate
- Founded2015
- HeadquartersBeverly Hills, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
Kairos Ventures firmographics
Firmographics- Name
- Kairos Ventures
- Legal name
- Kairos Venture Investments, LLC
- Website
- https://kairosventures.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Where Kairos Ventures is headquartered
LocationHeadquarters
- HQ city
- Beverly Hills
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
Kairos Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Venture Capital Returns: Kairos generates returns through carried interest on successful portfolio company exits including acquisitions, IPOs, and secondary transactions. The firm invests in companies across life sciences and physical sciences sectors with the goal of significant impact and shareholder returns.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Early-stage investments from university spinouts |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Kairos Ventures product offering
Product offeringCore offering
Kairos Ventures is a venture capital firm that makes early-stage investments ranging from $150,000 to $20 million in formative companies spun out of top universities and scientists' research. The firm invests across life sciences and physical sciences sectors, providing hands-on operational expertise in legal, finance, marketing, operations, business development, and HR to help scientists commercialize their technologies into sustainable businesses while allowing founding teams to retain majority ownership.
Product overview
Kairos Ventures is a venture capital and investment firm that invests in ideas, patents, and businesses from the world's top universities and scientists. The firm invests early-stage capital (ranging from $150,000 to $20 million) in formative companies and works closely with scientists to commercialize their technologies. The portfolio includes over 30 active companies spanning life sciences (therapeutics, medical devices, diagnostics), physical sciences (advanced materials, semiconductors, aerospace), and sustainability sectors. Kairos provides hands-on support including expertise in legal, finance, marketing, operations, business development, and HR. The firm maintains corporate headquarters in Beverly Hills with regional offices in Pasadena, New York, Washington D.C., and Austin.
Differentiator
Problem solved
Functional benefit
Companies that use Kairos Ventures
Customer profileNamed customers11 records
Segments3 records
Ideal customer profiles2 records
Kairos Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Kairos Ventures partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
Kairos Ventures competitors and assessment
Company assessmentEmerging players
- In-Q-Tel: Strategic deep tech investor affiliated with the US intelligence community, funding university-originated technologies in semiconductors, photonics, and aerospace — directly comparable to MixComm-style investments in Kairos's portfolio.
- Material Impact: Early-stage fund focused on novel materials, advanced manufacturing, and physical sciences spinouts. Highly comparable to Kairos's physical sciences portfolio focus (e.g., PolyCera, nFugue, Mattiq).
Direct peers
- DCVC (Data Collective): Deep tech and science-driven venture firm investing in compute, materials, life sciences, and aerospace — directly overlapping with Kairos's physical sciences portfolio and university sourcing approach.
- ARCH Venture Partners: Pioneer in university-originated deep tech and life sciences investing, with similar focus on spinouts from top-tier research institutions and Nobel-laureate-adjacent founders. Closest model peer for early-stage science commercialization.
- Osage University Partners: Dedicated university technology transfer investor, partnering with research institutions to fund spinouts. Highly comparable university-tech-transfer sourcing model, though typically takes smaller equity stakes.
- Khosla Ventures: Leads/participates in early-stage deep tech and biotech rounds (e.g., Vivodyne Series A) with similar formative-stage and impact-oriented thesis. Comparable check sizes and stage focus to Kairos.
- Lux Capital: Early-stage VC specializing in university- and scientist-sourced deep tech across life sciences, semiconductors, AI, and aerospace. Most direct comparable to Kairos's university-tech-transfer model and sector mix.
- Section 32: Science-driven venture firm investing across biotech, life sciences, and frontier technology. Comparable thesis around university-sourced IP and operator-led support model.
Broad incumbents
- Andreessen Horowitz (a16z): Mega-VC with dedicated bio/health and deep tech franchises. Operates overlapping themes (AI, biotech, semiconductors) but with vastly greater AUM, brand, and platform resources.
- Founders Fund: Established deep tech and frontier technology investor. Overlapping sector mandate (aerospace, biotech, AI) but operates at much larger fund scale with broader stage range than Kairos.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Kairos Ventures social profiles
Digital presenceKairos Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kairos Ventures leadership team
Management profileNumber of profiles
Profiles16 records
Kairos Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kairos Ventures M&A and investment
M&A and investmentM&A
Investments64 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kairos Ventures
What does Kairos Ventures do?
Kairos Ventures is a venture capital firm that makes early-stage investments ranging from $150,000 to $20 million in formative companies spun out of top universities and scientists' research. The firm invests across life sciences and physical sciences sectors, providing hands-on operational expertise in legal, finance, marketing, operations, business development, and HR to help scientists commercialize their technologies into sustainable businesses while allowing founding teams to retain majority ownership.
Is Kairos Ventures a public or private company?
Kairos Ventures is a private company. It is classified as venture growth investor backed and is currently operating.
When was Kairos Ventures founded?
Kairos Ventures was founded in 2015. It employs 51 to 100 people.
Where is Kairos Ventures based?
Kairos Ventures is headquartered in Beverly Hills, United States, in the North America region.
How does Kairos Ventures make money?
One revenue line is on record: venture Capital Returns.
Who are Kairos Ventures's main competitors?
Emerging players on record are In-Q-Tel and Material Impact. Direct peers are DCVC (Data Collective), ARCH Venture Partners, Osage University Partners, Khosla Ventures, Lux Capital and Section 32. Broad incumbents are Andreessen Horowitz (a16z) and Founders Fund.
Does Kairos Ventures have an API?
No public API is recorded for Kairos Ventures.